
|Videos|January 19, 2021
HER2+ BC: A Year in Review and Updates from SABCS
Author(s)Targeted Oncology
A review of key relevant data on HER2-positive breast cancer from the 2020 SABCS Virtual Symposium.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts NDA for 177Lu-edotreotide in GEP-NETs
2
Rethinking Advanced Prostate Cancer: Surprising Finds from a Landmark Study
3
Long-Term Follow-Up Confirms Benefits of Low-Dose Seminoma Treatment
4
FDA Authorizes EXENT System to Aid Myeloma Diagnosis
5







































